Literature DB >> 15183133

Reflections on the occurrence and significance of antepartum fetal asphyxia.

James A Low1.   

Abstract

This chapter documents the growing evidence of the occurrence and significance of antepartum fetal asphyxia. Perinatal mortality studies demonstrate that the majority of fetal deaths, including those due to asphyxia, occur in the antepartum period. Epidemiological studies of cerebral palsy conclude that a minority of cases of cerebral palsy are due to intrapartum fetal asphyxia and implicate antenatal events, including asphyxia. Cordocentesis studies have confirmed that antepartum fetal asphyxia occurs in the growth-restricted fetus and might contribute to the increase of stillbirths and cerebral palsy in these children. Blood gas and acid-base studies in the immature fetus have demonstrated the increased prevalence of fetal asphyxia, and particularly of moderate or severe asphyxia, of which the majority might occur in the antepartum period. The ultimate determination of the prevalence and significance of antepartum fetal asphyxia requires the development of a non-invasive specific measure of fetal asphyxia.

Entities:  

Mesh:

Year:  2004        PMID: 15183133     DOI: 10.1016/j.bpobgyn.2004.02.002

Source DB:  PubMed          Journal:  Best Pract Res Clin Obstet Gynaecol        ISSN: 1521-6934            Impact factor:   5.237


  8 in total

1.  Evolving changes in fetal heart rate variability and brain injury after hypoxia-ischaemia in preterm fetal sheep.

Authors:  Kyohei Yamaguchi; Christopher A Lear; Michael J Beacom; Tomoaki Ikeda; Alistair J Gunn; Laura Bennet
Journal:  J Physiol       Date:  2018-01-30       Impact factor: 5.182

2.  Statin treatment depresses the fetal defence to acute hypoxia via increasing nitric oxide bioavailability.

Authors:  Andrew D Kane; Emilio A Herrera; Jeremy A Hansell; Dino A Giussani
Journal:  J Physiol       Date:  2011-11-21       Impact factor: 5.182

3.  Magnesium sulphate and cardiovascular and cerebrovascular adaptations to asphyxia in preterm fetal sheep.

Authors:  Robert Galinsky; Joanne O Davidson; Paul P Drury; Guido Wassink; Christopher A Lear; Lotte G van den Heuij; Alistair J Gunn; Laura Bennet
Journal:  J Physiol       Date:  2015-07-08       Impact factor: 5.182

4.  A role for xanthine oxidase in the control of fetal cardiovascular function in late gestation sheep.

Authors:  E A Herrera; A D Kane; J A Hansell; A S Thakor; B J Allison; Y Niu; D A Giussani
Journal:  J Physiol       Date:  2012-02-13       Impact factor: 5.182

5.  Assessing cardiac and neurological maturation during the intrauterine period.

Authors:  Curtis L Lowery; R B Govindan; Pamela Murphy; Hari Eswaran
Journal:  Semin Perinatol       Date:  2008-08       Impact factor: 3.300

Review 6.  Glucocorticoids and preterm hypoxic-ischemic brain injury: the good and the bad.

Authors:  Laura Bennet; Joanne O Davidson; Miriam Koome; Alistair Jan Gunn
Journal:  J Pregnancy       Date:  2012-08-16

7.  The effects of pravastatin on the normal human placenta: Lessons from ex-vivo models.

Authors:  Adelina Balan; Irit Szaingurten-Solodkin; Shani S Swissa; Valeria Feinshtein; Mahmoud Huleihel; Gershon Holcberg; Doron Dukler; Ofer Beharier
Journal:  PLoS One       Date:  2017-02-15       Impact factor: 3.240

8.  Maternal-to-fetal allopurinol transfer and xanthine oxidase suppression in the late gestation pregnant rat.

Authors:  Andrew D Kane; Emily J Camm; Hans G Richter; Ciara Lusby; Deodata Tijsseling; Joepe J Kaandorp; Jan B Derks; Susan E Ozanne; Dino A Giussani
Journal:  Physiol Rep       Date:  2013-11-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.